Position in VCYT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,613,773
New position
Shares Held
299,911
first reported quarter
Ownership
0.373%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#52
of 367 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Freestone Grove Partners LP holds $466,937,121 across 15 Diagnostics & Research names. VCYT ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
226,238 | $113,426,683 | |
| 2 | A |
Agilent Technologies, Inc.
|
685,699 | $91,081,398 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
65,767 | $84,018,000 | |
| 4 | QGEN |
Qiagen N.V.
|
1,311,722 | $51,288,330 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
200,320 | $38,705,830 | |
| 6 | RVTY |
Revvity, Inc.
|
330,003 | $36,716,133 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
60,557 | $31,879,627 | |
| 8 | VCYT |
Veracyte, Inc.
This page
|
299,911 | $17,613,773 |
All Filings in VCYT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,613,773 | 299,911 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||